Zhejiang Yatai Pharmaceutical News

Asia-Pacific Pharmaceutical Industry (002370) in-depth report: pharmaceutical Innovation whole Industry chain platform

太平洋證券Jun 22, 2018 00:00

Asia-Pacific Pharmaceutical (002370) Annual report and Quarterly report comments: CRO business rapid growth preparation business turned up

萬聯證券May 2, 2018 00:00

Asia Pacific Pharmaceutical (002370) Annual Report Review: Encouraging Rapid Growth in the Company's CRO Performance by Encouraging Innovation

西南證券Apr 24, 2018 00:00

Review of Asia-Pacific Pharmaceutical (002370) Annual report and Quarterly report: CRO Service & the platform of Pharmaceutical Innovation Industry chain with High growth of Pharmaceutical preparations

太平洋證券Apr 24, 2018 00:00

Asia-Pacific Pharmaceutical (002370) Annual report comments: preparation recovery + CRO rapid growth performance is expected to continue high growth

西南證券Apr 23, 2017 00:00

Asia-Pacific Pharmaceutical (002370) Company follow-up report: new students re-recognition: high barriers, high growth build three platforms throughout the pharmaceutical R & D service industry chain

方正證券Mar 20, 2017 00:00

Comment on the incident of Asia-Pacific Pharmaceutical (002370) Company: Shengyuan parent company Shuangfa Power Company has entered the channel of rapid growth of performance.

方正證券Feb 27, 2017 00:00

YATAI PHARMACEUTICAL(002370)：ITS OWN FORMULATION BUSINESS POSTED RELATIVELY LOW GROWTH;THE ACQUIRED FIRM LIKELY TO BEAT 2016 PROFIT COMMITMENT

中信證券Nov 3, 2016 00:00

Asia-Pacific Pharmaceutical Industry (002370) Quarterly report comments: the parent company's preparation business growth rate is low, new students are expected to exceed the performance target for the whole year.

中信證券Nov 1, 2016 00:00

Asia-Pacific Pharmaceutical (002370) Quarterly report comments: parent company's performance is lower than expected CRO continues the trend of rapid growth

西南證券Oct 31, 2016 00:00

【西南证券】亚太药业:母公司业绩低于预期,CRO延续快速成长态势

西南證券Oct 30, 2016 00:00

亚太药业(002370)深度报告：高起点转型CRO 戴维斯双击可期

方正證券Sep 9, 2016 00:00

亚太药业(002370)深度报告：估值和业绩有望同步提升的CRO行业新秀

西南證券Sep 7, 2016 00:00

亚太药业(002370)中报点评：财务费用拖累本部业绩 CRO全年业绩或超预期

西南證券Aug 29, 2016 00:00

亚太药业(002370)中报点评：CRO维持高速增长 制剂业务利润有望大幅增厚

方正證券Aug 29, 2016 00:00

【方正证券】亚太药业:CRO维持高速增长,制剂业务利润有望大幅增厚

方正證券Aug 28, 2016 00:00

【西南证券】亚太药业:财务费用拖累本部业绩,CRO全年业绩或超预期

西南證券Aug 28, 2016 00:00

亚太药业(002370)点评：估值和业绩有望同步提升的CRO新秀

西南證券Jul 19, 2016 00:00

【国信证券】亚太药业:打造CRO资源整合平台

國信證券Jul 19, 2016 00:00

亚太药业(002370)深度报告：打造CRO资源整合平台

國信證券Jul 19, 2016 00:00